NLR family pyrin domain containing 12 (NLRP12) inhibits the Wnt/β-catenin pathway by interacting with serine/threonine kinase 38 (STK38), thereby suppressing CRC development and progression [260]. This evidence concerns the gene NLRP12 and colorectal carcinoma.